SCHEMBL5756080

SCHEMBL5756080

N#Cc1cccc(COc2ccc(CNc3c(Cl)ccc4c3CCC(C(=O)C(F)(F)F)CN4)cc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.40
FFAR1 O14842 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40
PDCD1 Q15116 4/20 0.37
CD274 Q9NZQ7 4/20 0.37
MRGPRX4 Q96LA9 3/20 0.37
ENPP2 Q13822 1/20 0.36
GRM5 P41594 1/20 0.36
ALOX5 P09917 1/20 0.36
ALOX5AP P20292 1/20 0.36
ADAM17 P78536 2/20 0.36
MMP1 P03956 1/20 0.35
MAOB P27338 2/20 0.35
MAOA P21397 1/20 0.35
CYP4F2 P78329 1/20 0.35
CYP4A11 Q02928 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
SLC6A4 P31645 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5736358 0.78 ALDH1A1 (0.37)
SCHEMBL5763645 0.77 ALDH1A1 (0.33) KCNH2
SCHEMBL506817 0.76 FFAR1 (0.42) KCNH2FFAR1FFAR4PDCD1CD274
SCHEMBL5755390 0.76 P2RX7 (0.32)
SCHEMBL5765971 0.73 TLR7 (0.32) FFAR4CD274
SCHEMBL10228013 0.73 MAOB (0.43) KCNH2FFAR1FFAR4PDCD1CD274
Succinic Acid SCHEMBL507624 0.73 FFAR1 (0.52) KCNH2FFAR1FFAR4PDCD1CD274
SCHEMBL4775977 0.73 TBK1 (0.38)
SCHEMBL4778531 0.71
SCHEMBL5757418 0.70 KDM4E (0.32) SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720836-A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO [D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2006-11-15 EP disclosed
WO-2005082859-A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2005-09-09 WO disclosed